Starting at 2.5 mg , the schedule proceeds to 5 mg, 7.5 mg, 10 mg, 12.5 mg, and finally 15 mg
Even injection users find tablets appealing More than two thirds ( 71.88% ) of previous GLP-1 injection users said a daily tablet feels more appealing than a weekly injection, while 66.67% of current injection users agreed, showing strong interest in oral options even among experienced users
But virtually all of them are overhyped at this point. There are promising results popping up in petri dishes (in vitro studies) and in animal models, but human data is very limited at this point. Norton says hes cautiously optimistic about the true potential of peptides, but given that less than 50% of animal study findings carry over to humans, these compounds really should be vigorously tested in human trials before being marketed to the public. The digestion process may make many of these peptides biologically inert, as digestive enzymes can break them down, though there are some measures that can be taken to protect them during this process
These belong to a class of medicines called GLP-1 receptor agonists, which lower blood sugar, suppress appetite and prolong satiety by mimicking gut hormones
